Kantonsspital Luzern

Running trials

• Recruiting

  Early Detection and IntervenTion in Heart Failure

  NCT07731490· Source

• Recruiting

  Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance

  NCT06936774· Phase 3· Source

• Recruiting

  Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion

  NCT05596578· Source

• Active, not recruiting

  EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke

  NCT05029414· Source

• Active, not recruiting

  Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

  NCT04662255· Phase 3· Source

• Active, not recruiting

  Emergency Department Triage of Patients With Acute Chest Pain Based on the ESC 0/1-hour Algorithm (PRESC1SE-MI)

  NCT05649384· Source

• Active, not recruiting

  A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

  NCT03157128· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Heart failure1 recruiting
• Lung cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

  NCT05499832· Phase 3· Source

• Completed

  ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS

  NCT05458908· Source

• Completed

  Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

  NCT03353831· Phase 3· Source

• Completed

  Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

  NCT01272050· Phase 3· Source

• Terminated

  SwissNET - a Registry for Neuroendocrine Tumours in Switzerland

  NCT01039922· Source